|
|
|
|
| LEADER |
00898nas a22002292 4500 |
| 001 |
ebs8309330e |
| 003 |
EBZ |
| 006 |
m d |||||| |
| 007 |
cr|unu|||||||| |
| 008 |
200707| xx uu p s 0 0eng d |
| 022 |
|
|
|y 0167-6997
|
| 035 |
|
|
|a (EBZ)ebs8309330e
|
| 040 |
|
|
|a EBZ
|
| 042 |
|
|
|a msc
|
| 130 |
0 |
|
|a Investigational new drugs [Invest New Drugs] NLMUID: 8309330 (Online)
|
| 222 |
1 |
0 |
|a Investigational new drugs [Invest New Drugs] NLMUID: 8309330
|
| 245 |
0 |
0 |
|a Investigational new drugs [Invest New Drugs] NLMUID: 8309330
|h [electronic resource].
|
| 773 |
0 |
|
|t MEDLINE with Full Text
|d EBSCO
|
| 856 |
4 |
0 |
|3 Full text available: Jan 2005-. (Due to publisher restrictions, the most recent 12 Month are not available).
|z Available in MEDLINE with Full Text.
|u https://search.ebscohost.com/direct.asp?db=mnh&jid=%228309330%22&scope=site
|
| 999 |
|
|
|c 135344
|d 135344
|
| 942 |
|
|
|z EBS
|
| 942 |
|
|
|c REL
|